163 related articles for article (PubMed ID: 2899520)
21. Dopamine receptor affinities in vitro and neurochemical effects in vivo of pergolide and its metabolites.
Wong DT; Threlkeld PG; Bymaster FP
Arzneimittelforschung; 1993 Apr; 43(4):409-12. PubMed ID: 7684223
[TBL] [Abstract][Full Text] [Related]
22. Effect of timiperone on 3H-spiroperidol binding to rat striatal dopamine receptors.
Tachizawa H; Sudo K; Sano M
Eur J Pharmacol; 1979 Nov; 59(3-4):245-51. PubMed ID: 43256
[TBL] [Abstract][Full Text] [Related]
23. Agonist interactions with dopamine receptors: focus on radioligand-binding studies.
Creese I; Sibley DR; Leff SE
Fed Proc; 1984 Oct; 43(13):2779-84. PubMed ID: 6383871
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis and properties of several heterocyclic dopaminergic ligands.
Kostić S; Soskić V; Joksimović J
Arzneimittelforschung; 1994 Jun; 44(6):697-702. PubMed ID: 7914413
[TBL] [Abstract][Full Text] [Related]
25. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
Leff SE; Creese I
Mol Pharmacol; 1985 Feb; 27(2):184-92. PubMed ID: 3969067
[TBL] [Abstract][Full Text] [Related]
26. Relative activities of SCH 23390 and its analogs in three tests for D1/DA1 dopamine receptor antagonism.
Barnett A; Ahn HS; Billard W; Gold EH; Kohli JD; Glock D; Goldberg LI
Eur J Pharmacol; 1986 Sep; 128(3):249-53. PubMed ID: 2878816
[TBL] [Abstract][Full Text] [Related]
27. Interaction of [3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex.
Chatterjee TK; Scott CE; Vazquez DM; Bhatnagar RK
Mol Pharmacol; 1988 Apr; 33(4):402-13. PubMed ID: 3357484
[TBL] [Abstract][Full Text] [Related]
28. Effects of chronic antidepressant treatment on dopamine-related [3H]SCH 23390 and [3H]spiperone binding in the rat striatum.
Paetsch PR; Greenshaw AJ
Cell Mol Neurobiol; 1992 Dec; 12(6):597-606. PubMed ID: 1490276
[TBL] [Abstract][Full Text] [Related]
29. D-2 dopamine receptors in aging mouse striatum: determination of high- and low-affinity agonist binding sites.
Severson JA; Randall PK
J Pharmacol Exp Ther; 1985 May; 233(2):361-8. PubMed ID: 3158731
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.
Chipkin RE; Iorio LC; Coffin VL; McQuade RD; Berger JG; Barnett A
J Pharmacol Exp Ther; 1988 Dec; 247(3):1093-102. PubMed ID: 2905002
[TBL] [Abstract][Full Text] [Related]
31. Pharmacology of binding of 3H-SCH-23390 to D-1 dopaminergic receptor sites in rat striatal tissue.
Faedda G; Kula NS; Baldessarini RJ
Biochem Pharmacol; 1989 Feb; 38(3):473-80. PubMed ID: 2563653
[TBL] [Abstract][Full Text] [Related]
32. Investigation of rat striatal dopamine D-1 receptors solubilized by digitonin with a precipitation method.
Zhang X; Segawa T
Eur J Pharmacol; 1989 Aug; 166(3):401-10. PubMed ID: 2680521
[TBL] [Abstract][Full Text] [Related]
33. Binding characteristics of the dopamine agonist/antagonist [3H]terguride (transdihydrolisuride) in the rat striatum.
Valchár M; Vrsecká M; Krejcí I; Dlabac A
Eur J Pharmacol; 1987 Apr; 136(1):97-101. PubMed ID: 3297739
[TBL] [Abstract][Full Text] [Related]
34. Preferential inhibition of ligand binding to calf striatal dopamine D1 receptors by SCH 23390.
Cross AJ; Mashal RD; Johnson JA; Owen F
Neuropharmacology; 1983 Nov; 22(11):1327-9. PubMed ID: 6141534
[TBL] [Abstract][Full Text] [Related]
35. Binding of a conformationally restricted dopamine analogue, 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, to receptors on rat brain synaptic membranes.
Roberts PJ; Woodruff GN; Poat JA
Mol Pharmacol; 1977 May; 13(3):541-7. PubMed ID: 17829
[No Abstract] [Full Text] [Related]
36. Structural determinants of selective affinity for brain D-1 dopamine receptors within a series of 1-phenyl-1H-3-benzazepine analogues of SK&F 38393 and SCH 23390.
O'Boyle KM; Waddington JL
Eur J Pharmacol; 1985 Sep; 115(2-3):291-5. PubMed ID: 2866103
[TBL] [Abstract][Full Text] [Related]
37. [3H]Fluphenazine binding to brain membranes: simultaneous measurement of D-1 and D-2 receptor sites.
Morgan DG; Finch CE
J Neurochem; 1986 May; 46(5):1623-31. PubMed ID: 2937884
[TBL] [Abstract][Full Text] [Related]
38. 3-Methoxytyramine accumulation: effects of typical neuroleptics and various atypical compounds.
Saller CF; Salama AI
Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct; 334(2):125-32. PubMed ID: 2878374
[TBL] [Abstract][Full Text] [Related]
39. Radioreceptor binding reveals the potencies of N,N-disubstituted 2-aminotetralins as D2 dopamine agonists.
Beart PM; Cook CJ; Cincotta M; de Vries DJ; Tepper P; Dijkstra D; Horn AS
Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):487-93. PubMed ID: 2963964
[TBL] [Abstract][Full Text] [Related]
40. [3H]-domperidone labels only a single population of receptors which convert from high to low affinity for dopamine in rat brain.
Grigoriadis D; Seeman P
Naunyn Schmiedebergs Arch Pharmacol; 1986 Jan; 332(1):21-5. PubMed ID: 2869417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
